We recently compiled a list of the 10 Best Fortune 500 Stocks To Buy Now. In this article, we are going to take a look at ...

CVS Health (NYSE:CVS) subsidiary Oak Street Health has reached a $60M settlement with the Department of Justice to resolve ...

The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially ...

CVS Health Corp (CVS) stock saw a modest uptick, ending the day at $58.42 which represents a slight increase of $0.59 or 1.02% from the prior close of $57.83. The stock opened at $57.88 and touched a ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.

CVS Health Corp. closed $24.83 short of its 52-week high ($83.25), which the company reached on January 8th.

CVS Health Corp. closed $24.85 short of its 52-week high ($83.25), which the company reached on January 8th.

CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services ...